Nanomedicines for Overcoming Cancer Drug Resistance

Clinically, cancer drug resistance to chemotherapy, targeted therapy or immunotherapy remains the main impediment towards curative cancer therapy, which leads directly to treatment failure along with extended hospital stays, increased medical costs and high mortality. Therefore, increasing attention...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Tingting, Gong, Hanlin, Xu, Jiayue, Huang, Yuan, Wu, Fengbo, He, Zhiyao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412887/
https://www.ncbi.nlm.nih.gov/pubmed/36015232
http://dx.doi.org/10.3390/pharmaceutics14081606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412887/
https://www.ncbi.nlm.nih.gov/pubmed/36015232
http://dx.doi.org/10.3390/pharmaceutics14081606

Ejemplares similares